PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
-4.87%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$7.52B
AUM Growth
+$7.52B
(-19%)
Cap. Flow
-$663M
Cap. Flow
% of AUM
-8.82%
Top 10 Holdings %
Top 10 Hldgs %
42.45%
Holding
173
New
32
Increased
18
Reduced
39
Closed
33
Top Buys
| 1 |
LABP
Landos Biopharma, Inc. Common Stock
LABP
|
$141M |
| 2 |
BridgeBio Pharma
BBIO
|
$64.7M |
| 3 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$55.4M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
$49.5M |
| 5 |
Exact Sciences
EXAS
|
$46.6M |
Top Sells
| 1 |
Novavax
NVAX
|
$116M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$95.2M |
| 3 |
Neurocrine Biosciences
NBIX
|
$93.1M |
| 4 |
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
|
$90.4M |
| 5 |
NVTA
Invitae Corporation
NVTA
|
$73.5M |
Sector Composition
| 1 | Healthcare | 84.38% |
| 2 | Financials | 0.28% |
| 3 | Industrials | 0.21% |
| 4 | Consumer Discretionary | 0.02% |
| 5 | Materials | 0% |
